Microsens Biotechnologies is a scientific research and licensing company founded in 1998 to develop technologies for the rapid and sensitive detection of Transmlssible Spongiform Encephalopathies (TSEs) and other related protein aggregation diseases, such as Alzheimer's Disease and Parkinson's Disease -collectively known as the "Protein Conformation Disorders", or the “Protein Aggregation Diseases”

Microsens Biotechnologies is based at the London Bioscience Innovation Centre close to Central London where the company operates a dedicated category 3 level containment facility capable of handling Bovine Spongiform Encephalopathy (BSE), Scrapie, Chronic Wasting Disease (CWD) and Creutzfeldt - Jakob Disease (CJD) infected materials.